Biotech / Medical
Xencor (XNCR)
An SI Board Since January 2014
Posts SubjectMarks Bans Symbol
107 21 0 XNCR
Emcee:  scaram(o)uche Type:  Moderated
I've been putting some Xencor stuff here. No reason for doing so, just blogging in that thread with irrelevant stuff......

Subject 59375

And it's probably also worth the time, following the MGNX thread.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
107Xencor's quarterly revenue growth is NEGATIVE 9.3%.......SELL it!!! [graphiKyleLenn-March 16
106Xencor Doses First Patient in Phase 1 Study of XmAb®18087 MONROVIA, Calif. Lance Bredvold-February 23
105A break of 22.63 could move it up to 26.43. [graphic]hollyhunter-12/5/2017
104"Greatly attenuated" effect on platelets with sq 7195 Will be quite uscaram(o)uche-11/7/2017
103Sounds like they will not take 7195 forward independent of a partner. Janssen/Cscaram(o)uche111/7/2017
102Might be worth listening to the quarterly call, just starting. Discussion of Igscaram(o)uche-11/7/2017 (Just to give everyone a view of what is happening in literatuscaram(o)uche111/5/2017
100CSL/JNJ anti-CD123 bites dust... endpts.comscaram(o)uche-10/17/2017
99CEO said they designed their CD3/CD123 - 14045 - to be somewhat less potent, so tuck-1/23/2017
98Hey, Lance! The specificity of antibodies is determined by two identical portioscaram(o)uche112/7/2016
97Apparently everybody does want a good Fc whatever that might be. Your posts oftLance Bredvold-12/6/2016
96Company did not need money, and got this out the door, today, while again tradinscaram(o)uche112/6/2016
95You're welcome. Great sleuthing by that crew at twitter. Not one of the lescaram(o)uche-9/21/2016
94Thanks for the pointer. stock doesnt seem to be getting hammered by the news. mopgcw-9/21/2016
93pointer from @ADC_drugs........ (says "Expect IMGN632 in 16scaram(o)uche-9/21/2016
92keep looking through that same thread at twitter, and you'll find a pointer scaram(o)uche-9/21/2016
91 >> CD123 is a fave marker << JNJ/Genmab project suspended, severe scaram(o)uche-9/21/2016
90CD123 is a fave marker, extending back to mid-90s. Believe that phase I resultsscaram(o)uche-9/14/2016
89This is a very nice wrinkle..... "mid single-digit tiered royalties for worscaram(o)uche-9/7/2016
88Both of today's PRs emphasized their perceived advantages, using full lengthscaram(o)uche-6/28/2016
87$150 million upfront, Fc's are the "product"........ Xencor Annouscaram(o)uche-6/28/2016
86Came back 50% from 2015 high, on good news. Price:book < 3.5, plenty of cashscaram(o)uche-9/29/2015
85>> anti-CD123 << Xencor's Partner Initiates Phase 2 Clinical Trscaram(o)uche-9/29/2015
84Amgen And Xencor Announce Strategic Collaboration In Cancer Immunotherapy And Inscaram(o)uche19/16/2015
83All-time high, up on a tough day. :-)scaram(o)uche-6/29/2015
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.